Steady State Kinetics of l-Methamphetamine and Validation of Sensitivity of Dose Estimation

NACompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

October 31, 2008

Primary Completion Date

September 30, 2009

Study Completion Date

September 30, 2009

Conditions
Nasal Congestion
Interventions
DRUG

l-methamphetamine

5mg of l-methamphetamine per day throughout the 2 week study

DRUG

d-methamphetamine

15mg on Study Day 9, 30mg on Study Day 11, 45mg on Study Day 13

Trial Locations (1)

94110

CPMC Addiction & Pharmacology Research Laboratory (APRL), San Francisco

All Listed Sponsors
collaborator

San Francisco General Hospital

OTHER

collaborator

University of California, San Francisco

OTHER

collaborator

National Institutes of Health (NIH)

NIH

lead

California Pacific Medical Center Research Institute

OTHER